An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

PHASE3CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

March 28, 2013

Primary Completion Date

June 16, 2015

Study Completion Date

September 4, 2018

Conditions
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Interventions
DRUG

Placebo

Two placebo capsules orally BID

DRUG

dimethyl fumarate

Two dimethyl fumarate 120mg capsules orally BID

Trial Locations (54)

100

National Taiwan University Hospital, Taipei

704

National Cheng Kung University Hospital, Tainan City

10408

National Cancer Center, Gyeonggi-do

11217

Taipei Veterans General Hospital, Taipei

41529

Krajska zdravotni, a.s. - Nemocnice Teplice, o.z., Teplice

42415

Yeungnam University Hospital, Daegu

50003

Privatni ordinace - neurologie, Hradec Králové

58633

Nemocnice Jihlava, Jihlava

656 91

Fakultni nemocnice u sv. Anny v Brne, Brno

736 00

Neurospol, s.r.o., Havířov

500 05

Fakultni nemocnice Hradec Kralove, Hradec Králové

775 20

Fakultni nemocnice Olomouc, Olomouc

128 08

Fakultni poliklinika VFN, Prague

150 06

Fakultni nemocnice v Motole, Prague

070-8644

NHO Asahikawa Medical Center, Asahikawa-shi

113-8431

Juntendo University Hospital, Bunkyō City

260-8677

Chiba University Hospital, Chiba

812-8582

Kyushu University Hospital, Fukuoka

920-0293

Kanazawa Medical University Hospital, Kahoku-gun

350-8550

Saitama Medical Center, Kawagoe-shi

650-0017

Kobe University Hospital, Kobe

187-8551

National Center Hospital, NCNP, Kodaira-shi

606-8507

Kyoto University Hospital, Kyoto

616-8255

NHO Utano Hospital, Kyoto

020-8505

Iwate Medical University Hospital, Morioka

951-8520

Niigata University Medical & Dental Hospital, Niigata

556-0016

Irino Clinic, Inc., Osaka

589-8511

Kindai University Hospital, Osakasayama-shi

145-0065

Tokyotohokeniryokosya Ebara Hospital, Ōta-ku

063-0005

NHO Hokkaido Medical Center, Sapporo

065-0021

CEReS Sapporo Neurology Clinic, Sapporo

980-8574

Tohoku University Hospital, Sendai

160-8582

Keio University Hospital, Shinjuku-ku

162-8666

Department of Neurosurgery, Tokyo Women's Medical University, Shinjuku-ku

565-0871

Osaka University Hospital, Suita-shi

359-8513

National Defense Medical College Hospital, Tokorozawa-shi

791-0295

Ehime University Hospital, Toon-shi

305-8576

Tsukuba University Hospital, Tsukuba

755-8505

Yamaguchi University Hospital, Ube-shi

276-8524

Tokyo Womens Medical University Yachiyo Medical Center, Yachiyo-shi

236-0004

Yokohama City University Hospital, Yokohama

80-803

Copernicus Podmiot Leczniczy Sp. z o.o., Gdansk

40-571

M.A. - LEK A.M.Maciejowscy SC., Katowice

40-650

Nzoz Novo-Med, Katowice

40-749

Neuro-Care Gabriela Klodowska, Katowice

31-637

MCD Medical, Krakow

90-324

Centrum Neurologii K. Selmaj, Lodz

62-064

Neurologiczny NZOZ Centrum Leczenia SM, Plewiska

61-853

"NZOZ NEURO-KARD, Ilkowski i Partnerzy Sp. Partn. Lek.", Poznan

04-749

Miedzyleski Szpital Specjalistyczny, Warsaw

02841

Korea University Anam Hospital, Seoul

03080

Seoul National University Hospital, Seoul

05505

Asan Medical Center, Seoul

06351

Samsung Medical Center, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY

NCT01838668 - An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) | Biotech Hunter | Biotech Hunter